Overview
- 48 inspections across 45 sites are on record.
- 145 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-22.
At a glance
Inspections
48
Sites
45
Observations
145
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent Pharma Solutions LLC | 22 May 2026 | Human Drugs | On file |
| American Regent, Inc. | 21 Apr 2026 | Human Drugs | On file |
| J & H Fulfillment, LLC. | 25 Mar 2026 | Human Drugs | |
| The Gillette Company | 24 Mar 2026 | Human Drugs | |
| Pharmaceutics International, Inc. | 6 Mar 2026 | Human Drugs | On file |
Sites inspected
Catalent Pharma Solutions LLCMorrisville, United States1 insp.
American Regent, Inc.Shirley, United States1 insp.
J & H Fulfillment, LLC.Elmhurst, United States1 insp.
The Gillette CompanyNorth Chicago, United States1 insp.
Pharmaceutics International, Inc.Cockeysville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Gam S Zamil5 shared
Syeda N Mahazabin4 shared
Divek R Jumani3 shared
Vivin George3 shared
Ruben C Quintana3 shared
Brandy N Lepage3 shared
Tomika L Crafter2 shared
Pushpa S Jayasekara2 shared
Luxuly Abraham2 shared
Amatul H Marium2 shared
Full investigator report
Get the verbatim findings behind Tanya R Syffrard's 145 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site